College of Medicine, University of Florida, Gainesville, FL, USA.
Department of Orthopaedic Surgery and Sports Medicine, University of Florida, Gainesville, FL, USA.
J Shoulder Elbow Surg. 2022 Nov;31(11):e545-e561. doi: 10.1016/j.jse.2022.06.026. Epub 2022 Aug 10.
Thoracic outlet syndrome (TOS) is a rare condition (1-3 per 100,000) caused by neurovascular compression at the thoracic outlet and presents with arm pain and swelling, arm fatigue, paresthesias, weakness, and discoloration of the hand. TOS can be classified as neurogenic, arterial, or venous based on the compressed structure(s). Patients develop TOS secondary to congenital abnormalities such as cervical ribs or fibrous bands originating from a cervical rib leading to an objectively verifiable form of TOS. However, the diagnosis of TOS is often made in the presence of symptoms with physical examination findings (disputed TOS). TOS is not a diagnosis of exclusion, and there should be evidence for a physical anomaly that can be corrected. In patients with an identifiable narrowing of the thoracic outlet and/or symptoms with a high probability of thoracic outlet neurovascular compression, diagnosis of TOS can be established through history, a physical examination maneuvers, and imaging. Neck trauma or repeated work stress can cause scalene muscle scaring or dislodging of a congenital cervical rib that can compress the brachial plexus. Nonsurgical treatment includes anti-inflammatory medication, weight loss, physical therapy/strengthening exercises, and botulinum toxin injections. The most common surgical treatments include brachial plexus decompression, neurolysis, and scalenotomy with or without first rib resection. Patients undergoing surgical treatment for TOS should be seen postoperatively to begin passive/assisted mobilization of the shoulder. By 8 weeks postoperatively, patients can begin resistance strength training. Surgical treatment complications include injury to the subclavian vessels potentially leading to exsanguination and death, brachial plexus injury, hemothorax, and pneumothorax. In this review, we outline the diagnostic tests and treatment options for TOS to better guide clinicians in recognizing and treating vascular TOS and objectively verifiable forms of neurogenic TOS.
胸廓出口综合征(TOS)是一种罕见的疾病(每 10 万人中有 1-3 例),由胸廓出口处的神经血管受压引起,表现为手臂疼痛和肿胀、手臂疲劳、感觉异常、无力和手部变色。TOS 可根据受压结构的不同分为神经源性、动脉性或静脉性。患者因先天性异常(如颈肋或起源于颈肋的纤维带)导致可客观证实的 TOS 而继发 TOS,这些异常会导致神经血管受压。然而,TOS 的诊断通常是在存在症状和体格检查发现的情况下做出的(有争议的 TOS)。TOS 不是排除性诊断,应该有可以纠正的物理异常的证据。在存在胸廓出口狭窄和/或胸廓出口神经血管受压高度可能的症状的患者中,通过病史、体格检查操作和影像学可以确立 TOS 的诊断。颈部创伤或反复工作压力可导致斜角肌疤痕形成或先天性颈肋移位,从而压迫臂丛神经。非手术治疗包括抗炎药物、减肥、物理治疗/强化锻炼和肉毒毒素注射。最常见的手术治疗包括臂丛神经减压、神经松解和斜角肌切开术,伴或不伴第一肋骨切除术。接受 TOS 手术治疗的患者应在术后就诊,开始被动/辅助肩部活动。术后 8 周,患者可开始进行阻力力量训练。手术治疗并发症包括锁骨下血管损伤,可能导致出血和死亡、臂丛神经损伤、血胸和气胸。在这篇综述中,我们概述了 TOS 的诊断测试和治疗选择,以更好地指导临床医生识别和治疗血管性 TOS 和可客观证实的神经源性 TOS。